IV Sets & Syringes — 5d 05h 06m
Policies & Compliance

Pharmacovigilance & Adverse Event Reporting

Patient safety monitoring for all TJL / LifeSol® products.

Last updated: June 2026

Our Responsibility

TJL Pharmaceutical continuously monitors the safety of its products. Healthcare professionals, distributors and patients are encouraged to report any adverse event, suspected side effect or safety concern associated with a LifeSol® product.

How to Report an Adverse Event

  • Email: contact@tjlhealthcare.com (subject line: 'Pharmacovigilance')
  • Phone: +44 208 200 0786
  • WhatsApp: +44 7403 069214
  • Include: product name, batch number, description of the event, patient age/sex (no name required), reporter contact details

What Happens Next

Every report is acknowledged, recorded and assessed by our quality and safety team. Where required, reports are escalated to the relevant regulatory authorities and, if a batch-level issue is suspected, our recall procedure is activated immediately.

Product Complaints vs Adverse Events

Product quality complaints (packaging, appearance, labelling) are handled under our Product Complaint Policy. If a quality issue is associated with a patient reaction, please report it as an adverse event so both processes are triggered.

Confidentiality

Reporter and patient information is handled confidentially and used solely for safety assessment and regulatory reporting purposes.

Questions about this policy?

Our team responds to all policy and compliance enquiries within one business day.

contact@tjlhealthcare.com

We use essential cookies to remember your language and improve your experience. Cookie Policy